Blood transfusion after myocardial infarction: friend, foe, or double-edged sword?
Alfonso
Fernando
F
D000367:Age Factors; D000740:Anemia / Q000150:complications; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation / Q000401:mortality; D017707:Erythrocyte Transfusion / Q000009:adverse effects* / Q000401:mortality; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011859:Radiography; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D012737:Sex Factors; D020521:Stroke / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors